WashU Medicine Knight ADRC

08/26/2026

Sunshine May Be Good for the Brain

As the days grow shorter, don’t forget to spend some time outdoors. Exposure to outdoor light may be good for the health of the brain, according to a new repo

08/26/2026

Study linking environmental factors and Alzheimer's disease awarded NIH funding - School of Medicine and Public Health

A nationwide study led by the University of Wisconsin School of Medicine and Public Health that explores the relationship between Alzheimer’s disease, environmental factors and lifetime experiences has been awarded a second round of funding from the National Institutes of Health (NIH).

08/26/2026

Deep sleep brain waves offer protection against Alzheimer’s disease, new research shows

A new international study led by Concordia researchers finds that stronger brain waves during deep sleep may protect people with Alzheimer’s against cognitive decline associated with elevated levels of the neurotransmitter orexin. The three-year study suggests that sleep quality could help slo...

08/26/2026

DNA organization changes in Alzheimer’s disease, aging

The 3D organization of DNA in cells changes in Alzheimer’s disease and aging, according to new research.

08/26/2026

FDA clears blood test to aid evaluation for Alzheimer’s disease

The biomarker test, called PrecivityAD2, was developed from technology invented at WashU Medicine by Randall J. Bateman, MD, and David M. Holtzman, MD.

08/25/2026

This year's will be a 2-part experience on 9/30 & 10/1 with Dr. Renã AS Robinson presenting "Measures to Achieve Equity in Alzheimer’s Disease Research." Learn more and register for one or both events at https://knightadrc.wustl.edu/center-events/seay-lecture/. We hope you will join us!

08/24/2026

FDA clears blood test to aid evaluation for Alzheimer's disease

The U.S. Food and Drug Administration (FDA) has cleared an innovative blood test for marketing. The test's underlying technology was invented at Washington University School of Medicine in St. Louis for the early diagnosis of Alzheimer's disease. The test, known as PrecivityAD2, was developed and va...

08/20/2026

The University of Rochester Medicine selected John Morris, MD, as the 2026 School of Medicine & Dentistry Distinguished Alumnus Award recipient!

The University of Rochester Medicine selected John Morris, MD, as the 2026 School of Medicine & Dentistry Distinguished Alumnus Award recipient! The recognition is presented to an alumnus who "exemplifies the standards and objectives of the School of Medicine & Dentistry through personal conduct, pr...

08/12/2026

Study of Brain Immune Cells Reveals New Clues to Alzheimer's Disease Progression - Neuroscience News

Researchers mapped 830,000 brain immune cells, uncovering a protective microglia subtype that clears harmful material and slows Alzheimer’s disease progression.

08/12/2026

Never-Before-Seen Type of Amyloid May Explain a Devastating Form of Alzheimer's

Alzheimer's disease is an incredibly challenging condition to study, because of both its complexity, and the many different ways it can vary between patients.